Sedation Regimens for Endoscopic Procedures

Medications and Dosage

The American Gastroenterological Association recommends a combination of propofol, an opioid, and a benzodiazepine as the most effective and safe sedation regimen for endoscopic procedures, providing better control of sedation with a lower risk of deep respiratory depression 1, 2
The combination of propofol with small doses of an opioid and a benzodiazepine allows for analgesia and amnesia with subhypnotic doses of propofol, eliminating the need for deep sedation 1, 2
The recommended dosages for colonoscopy are: propofol 65-100 mg, midazolam 0.5-1.0 mg, and fentanyl 50-75 mcg 2
The recommended dosages for upper endoscopy are: propofol 35-70 mg, midazolam 0.5-1.0 mg, and fentanyl 50-75 mcg 2

Midazolam is the benzodiazepine of choice due to its rapid onset of action and shorter duration 3
The initial recommended dose is 1-2 mg IV, with additional doses of 1 mg administered at 2-minute intervals as needed 3
Patients over 60 years old or with an ASA physical status of 3 or higher require a 20% or greater reduction in dose 3

Most protocols aim for moderate sedation rather than deep sedation 2
The combination of propofol, an opioid, and a benzodiazepine allows for maintenance of moderate sedation levels, where the patient can communicate at any time during the procedure 2
Required monitoring includes clinical and physiological parameters, pulse oximetry, and consideration of capnography in selected cases 2, 4

Patients with advanced liver disease may benefit from the short biological half-life of propofol 2
The combination of benzodiazepines and opioids may increase the risk of adverse cardiopulmonary events due to synergistic interaction 4
High-risk patients (ASA III-V, elderly, cardiac disease, cerebrovascular disease, significant pulmonary disease, liver failure, acute gastrointestinal bleeding, anemia, morbid obesity, and shock) require prior evaluation and dose modification 4
Pre-oxygenation and supplemental oxygen during the procedure may prevent hypoxemia 4
Antagonists such as naloxone and flumazenil should be available 3, 4

Patients over 60 years old require a 20% or greater reduction in midazolam dose 3, 5
Patients with liver or renal insufficiency require a reduction in midazolam dose 3

Certification in Advanced Cardiovascular Life Support (ACLS) is recommended 6
Adherence to practice guidelines for sedation administration and monitoring is necessary 6
Continuous education in sedation techniques is required 6
Basic skills in airway intervention are necessary 6